Researchers set out to determine the dosimetry levels of commonly performed interventional radiology procedures and compared those doses to commonly accepted reference levels in a July 3 Journal of the American College of Radiology study.

In a study of nearly 25,000 children, those whose mothers adhered to five healthy lifestyle factors carried a 75 percent lower risk of obesity than children whose mothers had none of those habits.

The American College of Radiology Data Science Institute (ACR DSI), which first launched in May 2017, has started releasing use cases from its TOUCH-AI library for industry feedback. A final release is scheduled for later this year.

Registered nurses employed at First Hospital in Kingston, Pennsylvania, reached a contract agreement with the hospital’s parent company, Tennessee-based Community Health Systems (CHS), that includes wage increases, health insurance and new protocols for floating nurses between units in the hospital.

On July 6, the U.S. and China began what many are calling a trade war by implementing billions of dollars in tariffs on each other's imported goods, including medical imaging equipment and artificial intelligence (AI).

CMS bumped back the due date for providers to opt into the Bundled Payments for Care Improvement (BPCI) Advanced model—moving the final date to Aug. 8 from Aug. 1. The move comes in amid growing concerns from those in the industry that claims data were not provided in a timely fashion.

Not offering breast cancer screening to low-risk women and implementing risk-stratified breast screening programs may improve the cost-effectiveness of screening programs and reduce overdiagnosis, according to research published July 5 in JAMA Oncology.

Australia’s Sir Charles Gairdner Hospital has opened the doors on a $21-million MRI renovation after more than a year of construction, government officials announced this week.

Government regulation can’t keep up with innovation in healthcare technology, especially when dealing with mobile medical applications—and those in charge of developing regulatory framework know it, according to top officials at the FDA in a July 2 viewpoint in JAMA.